FIBLAST TRAFERMIN IN TREATMENT OF INTERMITTENT CLAUDICATION

间歇性跛行的患者肌肉酸痛或 继发于脑缺血的活动时抽筋。这项研究的目的是 确定碱性成纤维细胞生长因子是否安全有效 治疗这些病人。这将决定碱性成纤维细胞生长因子是否能增加 由于血管供应的增加，持续的血液流动 通过新的毛细血管的形成和侧支循环的增加。参数设置为 接受测试包括运动成绩、机能状态、改善情况 小腿充血，双腿血流。

Patients with intermittent claudication experience muscle aching or cramping during activity secondary to ischemia. The aim of this study is to determine if basic Fibroblast Growth Factor is effective in safely treating these patients. It will determine whether bFGF can increase blood flow in a sustained fashion due to an increase in vascular supply via new capillary formation and increased collateral flow. Parameters to be tested include exercise performance, functional status, improvement of hyperemic calf flow, and lower limb blood flow.